Roadzen (NASDAQ: RDZN) director gets 152,732 stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Roadzen Inc. director Supurna VedBrat reported receiving a new stock option grant. On 09/15/2025, VedBrat was granted a stock option to buy 152,732 Roadzen ordinary shares at an exercise price of $2.00 per share. The option became exercisable on 09/15/2025 and will expire on 09/15/2032. Following this grant, VedBrat beneficially owned 152,732 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
VedBrat Supurna
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 152,732 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 152,732 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did Roadzen (RDZN) disclose in this Form 4?
The filing reports that director Supurna VedBrat was granted a stock option for 152,732 ordinary shares of Roadzen Inc.
What is the exercise price of the Roadzen (RDZN) stock options granted to Supurna VedBrat?
The stock option granted to Supurna VedBrat has an exercise price of $2.00 per share for the underlying Roadzen ordinary shares.
When do Supurna VedBrat’s Roadzen stock options vest and expire?
The stock option is listed as exercisable on 09/15/2025 and carries an expiration date of 09/15/2032.
How many Roadzen derivative securities does Supurna VedBrat own after this transaction?
After the reported transaction, Supurna VedBrat beneficially owned 152,732 derivative securities, held in direct ownership form.
What is Supurna VedBrat’s relationship to Roadzen Inc.?
Supurna VedBrat is identified in the filing as a director of Roadzen Inc., with no officer role or 10% ownership status indicated.
Was this Roadzen (RDZN) Form 4 filed for a derivative or non-derivative security?
This Form 4 relates to a derivative security, specifically a Stock Option (right to buy) Roadzen ordinary shares.